中天火箭：10月24日召开董事会会议

Group 1 - The core point of the article is that Zhongtian Rocket held its 25th meeting of the fourth board on October 24, 2025, to review the proposal for the third quarter report of 2025 [1] - For the first half of 2025, Zhongtian Rocket's revenue composition was entirely from small solid rockets and their extended products, accounting for 100.0% [1] - As of the time of reporting, Zhongtian Rocket's market capitalization was 8.2 billion yuan [1] Group 2 - The article also highlights that Chinese innovative drugs have generated $80 billion in overseas licensing this year, indicating a hot secondary market in biomedicine, while the primary market is facing fundraising challenges [1]